IndraLab

Statements


ATXN3 decreases the amount of CYP46A1. 1 / 1
| 1

reach
"Results : Our data indicate that CYP46A1 cerebellar levels are decreased by 46% in MJD patients and by 29% in MJD mice."
| PMC